The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...

Hims & Hers Health will continue offering low-cost compounded weight-loss shots even after Novo Nordisk terminated their partnership over alleged “deceptive marketing,” CEO Andrew Dudum said in his ...

We recently published Market on Mute? Not for These 10 Stocks With Surprising Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is ...

Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...

Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...

Andrew Dudum is a disrupter. In 2017 he founded Hims & Hers (NYSE: HIMS), a digital health startup with the goal of upending the traditional healthcare market.

Hims & Hers co-founder and CEO Andrew Dudum spoke on potentially getting into the glucagon-like peptide agonists, or GLP-1, weight loss drug market, how much the company spends marketing to ...

Hims & Hers CEO and Co-founder Andrew Dudum By Jarrett Banks Hims & Hers Health, Inc. (“Hims & Hers”) just completed its business combination with Oaktree Acquisition Corp. (NYSE: OAC), a SPAC ...

Andrew Dudum, the CEO and 10% Owner of Hims & Hers Health Inc (NYSE:HIMS), has recently sold a significant number of shares in the company. On December 1, 2023, the insider executed a sale of ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2021 Earnings Conference Call November 10, 2021 5:00 PM ETCompany Participants. Andrew Dudum - Chief Executive Officer Spencer Lee - Chief Financial Officer ...

Andrew Dudum, the co-founder and CEO of telehealth company Hims & Hers, on Monday sought to clarify a recent post on X (formerly Twitter) regarding on-campus protests against the war in Gaza.